General Safety & Performance Requirements — MR-scanner Related

Introduction to General Safety and Performance Requirements (GSPR)

For anyone new to medical device trials, understanding General Safety and Performance Requirements (GSPR) is crucial. These requirements form the foundation of regulatory compliance under the European Medical Device Regulation (MDR) and Swissmedic’s /  [or local responsible EU-CA]  corresponding regulations. GSPR documents are essential in demonstrating that a medical device meets the necessary standards for safety, performance, and efficacy. They serve as evidence that the device adheres to stringent health, safety, and environmental protection standards.

When submitting applications to Swissmedic /  [or local responsible EU-CA] and Cantonal Ethics Committees (CEC) for clinical investigations, GSPR documents are particularly important because:

  • Establishing Device Safety

    • They confirm that the investigational device is designed and manufactured in a way that ensures patient and user safety throughout its intended use.

  • Demonstrating Risk Mitigation

    • GSPR documentation outlines the measures taken to identify, evaluate, and mitigate risks associated with the device. This is critical for non-CE-marked components or investigational use.

  • Ensuring Compatibility

    • For devices combining CE-marked and non-CE-marked elements (e.g., investigational software or specialized RF coils), GSPR documents provide proof of compatibility and compliance with international safety standards like ISO 14971 (Risk Management) or IEC 60601 (Electromedical Equipment).

  • Regulatory Compliance

    • Swissmedic /  [or local responsible EU-CA] and CECs require detailed documentation to assess whether the investigational device complies with legal requirements. Failure to include comprehensive GSPR documents can lead to delays or rejection of your application.

For someone starting out, it can be overwhelming to gather and compile these documents. In my experience, these include:

  • Manufacturer-provided statements ensuring compliance with relevant ISO and IEC standards.
  • Risk management documentation.
  • Evidence of testing and performance verification.

When I began my journey into regulatory submissions, I lacked a clear understanding of what GSPR was or how it fit into the broader regulatory framework. With time and experience, I realized that these documents are not just a bureaucratic formality but a critical element that ensures patient safety and builds trust with regulatory authorities. In this section, I will share the key aspects of GSPR and how they are used in medical device trials, using official [or local responsible EU-CA]  documentation as an example to guide your understanding.

Required Documentation for CEC and Swissmedic / [or local responsible EU-CA]  Application

When preparing a clinical trial application involving investigational medical devices, detailed documentation is essential for both the Cantonal Ethics Committee (CEC) and Swissmedic / [or local responsible EU-CA] . For studies utilizing advanced equipment like the UHF Terra scanner, manufacturers such as [your scanner manufacturer] provide critical supporting materials that demonstrate compliance with regulatory and safety standards.

However, it is important to note that large parts of the documentation provided by [your scanner manufacturer] are confidential. Due to this confidentiality, I am unable to make these documents publicly downloadable in this post. To assist readers, I will instead provide a list of the file names along with a brief description of each document’s content. This approach will help you understand the scope and nature of the required documentation without breaching any confidentiality agreements.

It is also crucial to contact the manufacturer, such as [your scanner manufacturer], to request the specific documents that are most relevant to your planned investigation. The requested documentation should align with the scanner or hardware type, as well as the pulse sequences you intend to use. This ensures that the materials you provide in your application are tailored to your investigational setup and satisfy the regulatory requirements of Swissmedic / [or local responsible EU-CA] and the CEC.

In the following sections, I will outline the Terra scanner-related documents I included in my application, highlighting their significance in satisfying the General Safety and Performance Requirements (GSPR) and addressing the regulatory expectations of both Swissmedic / [or local responsible EU-CA] and the CEC.

Swissmedic [or local responsible EU-CA] Annex 12.3.1

  • [your-scanner-manufacturer]_01_Software_Development_Entwicklung_Statement.pdf

Summary and Recommendations: [your scanner manufacturer pulse sequence development environment]  

The document from [your scanner manufacturer], titled “Patient and Subject Safety with Measurement Sequences Developed Using the [name of the pulse sequence enviroment] Environment”, provides critical insights for researchers using [your scanner manufacturer/product line] MRI systems with custom-developed pulse sequences. Here’s a summarized view of its content and guidance for what you should request from your scanner manufacturer for your trial documentation:

Key Points of this [your scanner manufacturer] Document

  1. Purpose of the [your scanner manufacturer pulse sequence development] Framework

    • The IDEA (Integrated Development Environment for Applications) framework allows developers to create and modify measurement sequences for [your scanner manufacturer] MRI systems.
    • It supports customization of RF pulses, gradient field sequencing, and timing within regulatory safety limits set by IEC 60601-2-33, ensuring patient and system safety.

  2. Safety Controls

    • The [your scanner manufacturer / productline] systems include built-in hardware and software safety measures to ensure compliance with IEC 60601-2-33:
      • SAR Monitoring: Ensures tissue heating remains within safe thresholds.
      • Peripheral Nerve Stimulation (PNS) Monitoring: Prevents harmful stimulation caused by gradient fields.
    • Custom (non-CE-marked) sequences are installed separately from standard product sequences, preserving the system’s CE-marking for clinical use.

  3. Regulatory Guidance

    • Researchers using custom sequences must adhere to [your scanner manufacturer]-provided manuals (e.g., [your scanner manufacturer pulse sequence development environment] User Guide) and safety guidelines.
    • Responsibility for clinical applicability, accurate imaging, and compliance with local laws lies with the user, not [your scanner manufacturer].

  4. Special Case Usage

    • Temporarily overriding safety controls (e.g., for phantom studies) requires specific contracts and passwords from [your scanner manufacturer], along with regulatory approval for human studies.

Recommendations for Researchers

If you are conducting a medical device trial using custom sequences or non-CE-marked components, you should request specific documents from your scanner manufacturer. For example:

  1. Pulse Sequence Development Framework Documentation:
    • Includes guidelines on programming custom sequences, software validation, and safety checks.
  2. Safety and Performance Statements:
    • Documents outlining compliance with safety standards such as IEC 60601-2-33 and ISO 14971 (risk management).
    • Any manufacturer assurances about the compatibility of custom sequences with the base CE-marked system.
  3. Technical Specifications for Custom Use:
    • Information about SAR thresholds, PNS monitoring, and coil compatibility when using non-CE-marked components.
  4. Regulatory Agreements:
    • Agreements or contracts needed for trials involving investigational sequences, especially those requiring safety overrides or outside standard clinical mode.
  5. Test Protocols and Support:
    • Details on phantom testing, validation, and troubleshooting for investigational setups.

Importance for Medical Device Trials

Understanding and including these documents in your trial application is essential for meeting the General Safety and Performance Requirements (GSPR) mandated by the MDR and Swissmedic / [or local responsible EU-CA] . These materials demonstrate your investigational device’s safety and regulatory compliance, facilitating approval and ensuring patient safety during the study.

Final Note

For your trial, make sure to consult with [your scanner manufacturer] to obtain tailored documentation that aligns with your scanner model, investigational setup, and research objectives. Clear communication and early planning will save time and ensure smooth regulatory approval processes.

Swissmedic [or local responsible EU-CA] Annex 12.3.2

  • [your_scanner_manufacturer]_WIP_Sequences_Safety_Statement.pdf

Summary of the [your scanner manufacturer] Statement on Work in Progress (WIP) Sequences document

The document addresses the regulatory and safety considerations for the use of ASPs (AddIn Special Sequence Packages) and WIPs (Work in Progress Packages) in clinical research settings. Here are the key points:

  1. Non-Medical Device Classification

    • WIPs/ASPs are pre-clinical software packages, not classified as medical devices.
    • These packages require clinical evaluation to assess their diagnostic relevance and should not be used for diagnostic purposes, third-party benefits, or financial transactions.

  2. Regulatory Responsibility

    • The responsibility for obtaining necessary regulatory approvals (e.g., from Swissmedic or other authorities) lies solely with the user.

  3. Safety and CE-Mark Integrity

    • Installation and execution of WIPs/ASPs do not compromise the CE-mark of the [your scanner manufacturer / product line] system.
    • WIP sequences are subject to the same safety monitoring as CE-marked sequences, ensuring compliance with IEC 60601-2-33 standards for:
      • Specific Absorption Rate (SAR): Monitoring to prevent excessive tissue heating.
      • Peripheral Nerve Stimulation (PNS): Monitoring the dynamics of magnetic field gradients to prevent nerve stimulation.

  4. Built-in Safety Mechanisms

    • [your scanner manufacturer / product line] systems include integrated hardware and software that ensure adherence to SAR and PNS limits, regardless of WIP/ASP usage. These safety mechanisms cannot be bypassed.

  5. Liability and Assurance

    • [your scanner manufacturer] assumes liability for patient safety related to SAR and PNS, provided that unmodified [your scanner manufacturer] hardware (e.g., product coils) and software are used.

Guidance for Researchers

If you are planning to use WIP sequences in your study, it is crucial to:

  • Request Documentation:
    • Ensure you have a detailed description of the WIP’s intended purpose, safety features, and compliance with relevant safety standards (e.g., IEC 60601-2-33).
    • Obtain the manufacturer’s statements that the sequences will not compromise the system’s CE-mark and are monitored by built-in safety controls.
  • Clarify Regulatory Responsibilities:
    • Confirm that the investigational use of WIPs is approved by the necessary regulatory authorities.
    • Include these statements in your clinical trial application for Swissmedic /  [or local responsible EU-CA] and the CEC to demonstrate compliance.

This document reinforces the importance of adhering to regulatory requirements and maintaining safety protocols while leveraging the flexibility of investigational sequences for advanced research purposes.

Swissmedic [or local responsible EU-CA] Annex 12.3.3

  • [your scanner manufacturer]_Statement_Research_License_Mode.pdf

Summary of [your scanner manufacturer] Statement on Research License Mode

This document provides guidance and clarification on the Research License Mode available for [your scanner manufacturer / product line] systems, focusing on the safe use of non-standard sequences and hardware in research settings. Here are the key points:

  1. Research License Mode Functionality

    • This mode allows researchers to implement custom sequences or configurations for investigational purposes.
    • Custom sequences are executed separately from standard product software, preserving the system’s CE-marked status for clinical operations.

  2. Safety Measures 

    • SAR and PNS Compliance: The document reiterates that [your scanner manufacturer / product line] ‘ systems continuously monitor and enforce compliance with SAR (Specific Absorption Rate) and PNS (Peripheral Nerve Stimulation) limits as defined by IEC 60601-2-33.
    • These safety controls cannot be bypassed under normal Research License Mode operation, ensuring that investigational use maintains fundamental patient safety.

  3. User Responsibility

    • While [your scanner manufacturer] ensures compliance with SAR and PNS safety for standard system usage, the following remain the responsibility of the user:
      • Validating the accuracy of images and clinical applicability of custom sequences.
      • Conducting thorough testing of custom sequences, including phantom studies and safety validation.

  4. Regulatory and Legal Compliance

    • The document emphasizes that users are responsible for adhering to local laws and obtaining appropriate regulatory approvals (e.g., for clinical trials).
    • [your scanner manufacturer] explicitly states that it does not guarantee regulatory compliance for user-developed sequences and advises users to consult relevant regulatory bodies.

  5. Temporary Safety Override for Phantom Use

    • Researchers can request temporary access to bypass safety mechanisms (e.g., for non-clinical phantom testing), which requires specific contractual agreements and passwords provided by [your scanner manufacturer] . Such overrides are not permitted for human studies without appropriate clinical trial registration.

Key Takeaway for Researchers

When using [your scanner manufacturer / product line] systems in Research License Mode, it is crucial to:

  1. Request documentation that explains the system’s capabilities and limitations under research mode.
  2. Ensure compliance with safety standards like IEC 60601-2-33 for investigational sequences.
  3. Take full responsibility for validating the sequences’ safety, accuracy, and compliance with local regulations.

This document serves as a reminder that while [your_coil_manufacturer] provides robust safety controls, the regulatory and operational responsibility for investigational applications rests primarily with the researcher.

Swissmedic [or local responsible EU-CA] Annex 12.3.4

  • [your scanner manufacturer] _SytemOwnerManuel_Safety_Part.pdf

The [your scanner manufacturer/scanner type] System Owner Manual – Safety Information [software_release_identifier] provides essential guidelines and responsibilities for safely operating the [scanner type] MRI system. Below is a summary of the content relevant to a clinical investigation, along with a general note for readers who may require similar documentation:

Summary of Key Information in this Document

  1. Responsibility and Legal Compliance

    • The system owner is responsible for ensuring adherence to local laws and regulations regarding MRI operations.
    • Compliance with legal requirements, emergency planning, and employee qualifications is emphasized.

  2. Safety Features

    • The manual outlines the importance of MR-compatible safety systems, such as emergency switches, pre-screening procedures, and controlled access areas.
    • Essential safety features include RF door mechanisms, air conditioning for system cooling, and magnetic fringe field monitoring.

  3. Device and Personnel Interaction

    • Instructions are provided for informing MR workers and non-MR personnel (e.g., cleaning staff) about the specific hazards associated with the system.
    • All personnel must receive training on MR safety, including emergency scenarios such as magnet quenching or handling of RF coils.

  4. Maintenance and Repairs

    • Maintenance and repairs must be conducted by Siemens-authorized personnel to ensure safety and system integrity.
    • Daily and annual checks are recommended to identify environmental changes, system modifications, or potential hazards.

  5. Emergency Plans

    • Detailed procedures are described for managing emergencies such as quenching, fires, and equipment malfunctions. These include the use of magnet stop switches and coordination with fire departments.

  6. Pre-Screening Protocols

    • The manual stresses the need for pre-screening all patients and MR workers for contraindications like implants, pregnancy, or metal fragments.

General Advice for Researchers

If you are planning a clinical trial or a similar investigation, it is crucial to obtain the system-specific safety manual from the manufacturer of the MRI scanner you intend to use. Each manual is tailored to a specific hardware and software configuration, detailing safety measures, responsibilities, and operational guidelines. This ensures your project adheres to regulatory and safety requirements while also providing essential training and operational clarity for your team. In this case, the manual titled [your scanner manufacturer/scanner type] System Owner Manual – Safety Information [mr software version number] is specifically applicable.

For equivalent documentation, contact the manufacturer, ensuring the title and version correspond precisely to the equipment used in your trial.

Swissmedic [or local responsible EU-CA] Annex 12.3.5

  • [your scanner manufacturer/scanner type]_Operator_Manuals.pdf

The [your scanner manufacturer/scanner type] Operator Manual outlines the detailed procedures and safety considerations necessary for the operation of the MR-system in both clinical and investigational modes. Here’s a summary of its primary safety-relevant information, with a note to request a system-specific manual from [your scanner manufacturer] for your setup:

Key Safety-Related Aspects

  1. General Safety Guidelines

    • All personnel must adhere to the safety information outlined in this manual and other associated documents.
    • Proper training and understanding of RF coil handling, local and global SAR (Specific Absorption Rate), and general system precautions are mandatory.

  2. Specific Warnings and Precautions

    • Coil Handling: Regular inspections of RF coils are necessary. Damaged coils can result in patient burns and compromised image quality.
    • Local and Global SAR Compliance: Operators must follow Siemens’ guidelines for managing SAR to avoid thermal injuries. Irregular anatomy or improper B1-shim modes can lead to incorrect SAR estimations, necessitating additional vigilance.
    • Investigational Nature of the Device: The system is explicitly marked as investigational. It is not CE-marked for clinical use and must not be employed for diagnostic purposes outside an approved clinical trial.

  3. Modes of Operation

    • The [MR-scanner system type] can switch between single channel mode or 1Tx (clinical mode) and multi channel parallel mode pTx (research mode). The manual details these transitions and the associated responsibilities to maintain compliance and ensure patient safety.

  4. Warnings Related to pTx Technology

    • Parallel transmit (pTx) configurations introduce unique safety risks, such as the potential for local tissue overheating due to RF inhomogeneities. Operators must strictly use manufacturer-provided protocols to mitigate these risks.

  5. SAR and Gradient Control

    • Built-in software monitors SAR, ensuring that local and global thresholds are not exceeded. Gradient-induced peripheral nerve stimulation risks are similarly managed through automated safeguards.

  6. Investigational Labeling and DICOM Outputs

    • All images generated by the Terra system are labeled as investigational in their DICOM headers, reinforcing the system’s intended use in research contexts only.

Important Recommendation for Operators

For those planning to use Siemens MRI systems in their trials, it is essential to:

  • Request the most recent operator manual specific to the hardware and software version installed.
  • Obtain additional manufacturer-provided safety documentation tailored to the sequences and hardware configurations intended for investigational use.

This manual forms a critical component of your Swissmedic / [or local EU-CA] and Competent Ethics Committee applications, as it provides the foundational safety and operational details of the investigational device.

Swissmedic [or local responsible EU-CA] Annex 12.3.6

  • [your scanner manufacturer]_Master_Research_Agreement_[your research facility].pdf

The document entitled [your scanner manufacturer]_Master_Research_Agreement_[your research facility].pdf outlines a Master Research Agreement (MRA) and its Individual Project Agreements (IPAs), which govern collaboration between a research institution and [your scanner manufacturer] in the field of diagnostic imaging. Here’s a general summary of what such agreements typically include and the type of information that should be provided to ensure compliance in your own trial:

Summary of the Agreement

  • Purpose

    • The agreement establishes the terms under which Siemens provides resources, including software, hardware, and expertise, to facilitate research projects using their technology, such as MR scanners and related software tools.

  • Structure
    • The MRA serves as the overarching framework, under which Individual Project Agreements (IPAs) are created for specific projects. Each IPA defines:
    • The scope of work (e.g., developing MR pulse sequences or implementing new hardware).
    • Responsibilities and roles of both parties.
    • Equipment, software, or other materials provided by Siemens.

  • Confidentiality and Intellectual Property (IP)

    • Details on handling confidential information.
    • Rights to IP created during the research, including shared ownership of joint inventions.
    • Licensing terms for IP resulting from the collaboration, ensuring both parties can use the results for research or commercial purposes under specified conditions.

  • Equipment Use

    • [or local responsible EU-CA] provides equipment and software (e.g., WIP sequences or development tools like IDEA) for the research. The agreement specifies:
      • Intended use (e.g., for research only, not clinical diagnosis unless explicitly stated).
      • Safety measures and operational compliance.
      • Restrictions on equipment modifications or use with unapproved devices.

  • Responsibilities

    • [your scanner manufacturer] ensures that the provided equipment meets regulatory standards where applicable.
    • The research institution assumes responsibility for ethical compliance and obtaining necessary approvals for human or animal research.

  • Results Reporting 

    • Clear expectations for reporting results, including milestones and final deliverables.
    • Requirements for joint publications or presentations based on the research.

  • Termination and Liability

    • Terms for ending the collaboration.
    • Allocation of liability in case of equipment malfunction or misuse.

What to Request from Your Scanner Manufacturer

When preparing a Swissmedic / [or local responsible EU-CA]  or Competent Ethics Committee (CEC) application, ensure that your manufacturer provides:

  • Documentation on Research Use

    • Clear statements on the research-only nature of certain tools, like WIP sequences or non-CE-marked software.

  • Safety Assurance

    • Evidence that the provided equipment/software adheres to safety standards, even in research applications.

  • Detailed Specifications 

    • Documentation tailored to the exact hardware and software you plan to use (e.g., [your scanner type] scanner with [software version]).

  • Support for Regulatory Submissions

    • Support letters or agreements demonstrating the manufacturer’s acknowledgment of your project’s regulatory and safety requirements.

  • IP and Confidentiality Agreements

    • Clear terms on IP rights and confidentiality to protect both parties’ interests.

By incorporating these elements into your submission, you demonstrate to Swissmedic /  [or local responsible EU-CA]  and CEC that you’ve secured the necessary documentation and agreements to ensure your trial’s compliance with regulatory and ethical standards.

Swissmedic [or local responsible EU-CA] Annex 12.3.7

  • [your scanner manufacturer]_Conformity_Standards_[your MR scanner type]_Research.pdf

This document, titled Conformity with Standards for the [your scanner manufacturer] [your MR scanner type] (Research), provides an extensive declaration and evidence of the compliance of the device with numerous international safety, performance, and electromagnetic compatibility standards. These include IEC and EN standards for medical electrical equipment, software lifecycle processes, usability, biological evaluation, and risk management. The document is a critical piece for ensuring that the research system adheres to the required regulatory and safety frameworks.

Key Takeaways

  1. Comprehensive Standards Coverage

    • The document lists standards such as IEC 60601-1 for general safety and performance, IEC 60601-2-33 for MRI-specific safety, IEC 62304 for software processes, and EN ISO 14971 for risk management.
    • It ensures conformity across hardware, software, and usability aspects.

  2. Testing and Certification

    • Details specific test reports and evaluations performed by [your scanner manufacturer]/[scanner type], including electromagnetic compatibility and usability engineering.
    • Demonstrates compliance with both European and international standards, ensuring global applicability.

  3. Device-Specific Details

    • Includes hardware identifiers and specific configurations, such as short-term and long-term power ratings, operational modes, and system specifications for the [your scanner manufacturer]/[scanner type].

  4. Implications for Investigators

    • This document is essential for establishing the baseline safety and regulatory compliance of the scanner in clinical trials.
    • It provides confidence that the equipment operates within safe parameters and adheres to stringent regulatory requirements.

Note to Researchers

For your clinical trial application, ensure you request an equivalent Conformity with Standards document specific to the exact scanner model, software version, and hardware setup that you will use in your investigation. This ensures alignment with both regulatory and safety requirements for your planned device usage.

Swissmedic [or local responsible EU-CA] Annex 12.3.8

  • [your scanner manufacturer]_Safety_Statement_Usage_of_3rd_Party_Coils.pdf

Summary of Safety Statements on Third-Party RF Coil Usage

This document is a formal statement from [your scanner manufacturer], addressing the safety considerations for using third-party RF coils in conjunction with the [your scanner manufacturer][your scanner type] MRI system. It highlights the safety mechanisms built into the system and outlines the responsibilities for third-party coil providers and researchers.

Key Points

  1. Built-In Safety Mechanisms

    • The [your scanner manufacturer][your scanner type] MRI system includes robust safety features that ensure the safe operation of RF coils, whether provided by [your scanner manufacturer] or third-party manufacturers.
    • The system validates safety parameters up to the coil connection points, but third-party coil providers must ensure their products meet additional safety standards (e.g., IEC or NEMA).

  2. Interfacing Documentation

    • [your scanner manufacturer] provides detailed interfacing documentation under a confidentiality agreement to facilitate the integration of third-party RF coils.
    • This documentation includes mechanical, electrical, and software interface details, such as coil connectors, pin configurations, and the required “coil file” content.

  3. Third-Party Responsibilities 

    • The validation and safe operation of third-party coils are the sole responsibility of the coil provider.
    • This includes ensuring compliance with international safety standards and verifying the integrity of the “coil file” necessary for safe operation.

  4. PNS Safety Assurance 

    • Siemens affirms that third-party RF coils do not impact the Peripheral Nerve Stimulation (PNS) safety mechanisms of the MAGNETOM Terra system, ensuring that this critical safety feature remains effective.

Important Note for Researchers

If your investigation involves third-party RF coils, you must:

  • Request a safety statement specific to your MRI system from the MR-scanner manufacturer, such as stated above.
  • Ensure the third-party coil provider validates their product’s safety in compliance with international standards like IEC or NEMA.
  • Avoid reusing safety documentation addressed to another researcher or project. Manufacturers tailor these documents to specific setups and research agreements, making it essential to obtain personalized documentation for your trial.

This statement is vital for demonstrating safety compliance in clinical trial applications to regulatory bodies like Swissmedic / [or local responsible EU-CA]  or Competent Ethics Committees. It ensures transparency and mitigates risks when integrating non-standard components.

Swissmedic  [or local responsible EU-CA] Annex 12.3.9

  • [your scanner manufacturer][your scanner type]_SystemFlowChart.pdf

If you’re preparing a clinical trial application for Swissmedic / [or local responsible EU-CA] or the Competent Ethics Committee (CEC), you’ll come across technical documentation that might seem daunting at first. One such document is the “[your scanner manufacturer][your scanner type]_SystemFlowChart.pdf“ which provides a very deep dive into the operational details and configurations of the [your scanner type] MRI system. While this document is highly technical, it can play a crucial role in supporting your application.

This document outlines the system’s configuration for both CE-marked and investigational (non-CE-marked) modes, including features like parallel transmission (pTx) and the 1Tx mode. Typically such a document also describes how hardware and software components interact, offering a clear view of the system’s internal architecture and safety mechanisms, such as the scanner’s watchdog components.

If your trial involves investigational device setups or custom configurations, such as non-CE-marked pulse sequences or third-party RF-coils, a document like this can help demonstrate the integrity of your device’s design and the safety measures in place. It might not always be explicitly required by Swissmedic /  [or local responsible EU-CA]  or the CEC, but including it can add credibility to your application by showing that you’ve considered all technical and safety aspects of the system.

Important Advice: Always request this type of document directly from your scanner manufacturer, ensuring it matches your exact hardware and software setup. Generic or mismatched documentation won’t suffice, as reviewers will expect precise details tailored to your investigation.

In summary, while this document may seem technical, it provides critical information for regulatory compliance. If your setup involves unique configurations or investigational features, consider including a document like this in your trial submission—it can make a significant difference in conveying the safety and robustness of your overall non CE-marked investigational device.

Swissmedic  [or local responsible EU-CA] Annex 12.3.10

  • [your scanner manufacturer]_ConformityWithStandards_[your scanner type]_for_Research.pdf

Summary of a typical document of this type

This document is a formal declaration from [your scanner manufacturer] asserting that the [your scanner type] MRI system complies with a comprehensive set of international standards related to medical electrical equipment, software lifecycle processes, risk management, usability, and biological evaluation. The standards ensure the safety, performance, and quality management of the device in research applications.

Key Highlights of the Document

  1. Manufacturer and Device Identification

    • The MAGNETOM Terra MRI system is explicitly identified as a research device.
    • The document includes product identification details and is signed by regulatory and project management heads, lending credibility and regulatory authority.

  2. List of Standards

    • The document provides an exhaustive list of the standards that the Terra system adheres to, including:
      • IEC 60601-1: General requirements for basic safety and essential performance.
      • IEC 60601-2-33: Safety and performance of MRI systems.
      • IEC 62304: Software lifecycle processes.
      • EN ISO 14971: Risk management for medical devices.
      • EN ISO 10993-1: Biological evaluation within a risk management framework.
      • IEC 62366: Usability engineering for medical devices.
    • These standards ensure the system’s safety, performance, and quality for investigational use.

  3. Scope of Use

    • The document specifies that the device is intended for research and investigational purposes, reinforcing the need for compliance with stringent safety and performance standards.

  4. Testing and Validation

    • Standards related to electromagnetic compatibility (IEC 60601-1-2) and laser safety (IEC 60825-1) demonstrate the comprehensive testing and validation processes undergone by the device.

Why This Document is Necessary

  • Regulatory Compliance

    • When applying for Swissmedic / [or local EU-CA] and Competent Ethics Committee (CEC) approval, such a declaration is crucial to demonstrate that the investigational device adheres to internationally recognized safety and performance benchmarks.

  • Device-Specific Relevance

    • This document is tailored to the exact model and configuration of the MAGNETOM Terra system, ensuring it aligns with the specific hardware and software used in the trial.

  • Safety Assurance

    • It provides proof that the device has been rigorously tested and meets the required safety standards, a critical aspect of gaining approval for human research.

Guidance for Researchers

For your clinical trial application, ensure you request a similar conformity declaration document specific to your scanner model and configuration. This will help you:

  • Address safety and compliance requirements in your application.
  • Provide regulatory authorities with evidence of device conformity.
  • Avoid delays caused by missing or outdated documentation.

This document serves as a cornerstone in building a robust and compliant submission for investigational device trials. It reflects the manufacturer’s commitment to safety and quality, ensuring the device operates within established parameters.

Swissmedic  [or local responsible EU-CA] Annex 12.3.11

  • [your scanner manufacturer]_[your scanner type]_IEC60601-1_Excerpt.pdf

This document, could, typically, be entitled [your scanner manufacturer]/[your scanner type] IEC 60601-1 Medical Electrical Equipment Compliance Report, provides an extensive review of the compliance of the [your scanner manufacturer]/[your scanner type] MRI system with the IEC 60601-1 standards. It includes certifications, testing procedures, and conformity assessments performed by [your scanner manufacturer] (corporate) testing laboratory.

Key Points of the Document

  1. Scope and Purpose

    • The document establishes the safety and performance compliance of the Siemens Terra scanner with IEC 60601-1 standards, which are critical for ensuring the safe operation of medical electrical equipment in clinical and research environments.
    • It outlines the testing conducted for the 7 Tesla Terra system, including its key components and configurations.

  2. Testing Standards

    • Compliance with IEC 60601-1:2005 (Third Edition) + Amendments (A1:2012) is demonstrated. This standard focuses on the essential performance and safety of medical electrical devices.
    • National deviations for specific countries like the U.S. and Canada (ANSI/AAMI ES60601-1:2005) are addressed.

  3. Components Tested

    • The MRI scanner and its associated hardware, such as the RF transmission components and patient-handling subsystems, were examined under various operational conditions.
    • Software versions (e.g., xxx, yyy, zzz) were also reviewed for compliance.

  4. Safety Mechanisms

    • The document details critical safety measures, including:
      • SAR (Specific Absorption Rate) monitoring: Ensuring patient safety during MR scanning by regulating RF energy absorption.
      • Gradient slew rate limitations: To prevent nerve stimulation and maintain safe magnetic field operations.

  5. Importance for Research Proposals 

    • This report is essential for regulatory submissions to Swissmedic / [or local responsible EU-CA]  and Competent Ethics Committees (CEC). It validates that the scanner meets stringent safety and performance criteria.
    • Researchers planning studies on Siemens hardware should obtain a similar compliance report specific to their scanner’s model and configuration.

  6. Recommendation for Researchers 

    • If you plan to use  any manufacturer’s MRI system, request the latest compliance documentation relevant to your specific scanner type and configurations. These documents are critical for ensuring the alignment of your study with regulatory requirements and for addressing safety considerations.

Important Note for Researchers

By including this document in your Swissmedic /  [or local responsible EU-CA]  or CEC proposal, you provide evidence of adherence to internationally recognized safety standards, reinforcing the credibility and safety of your investigational device.

Leave a comment